Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink

Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. As a prospective treatment of such lesions, human-derived induced pluripotent stem cells (iPSCs) were shown to be 3D bioprinted into cartilage mimics using a nanofibrillated cellulos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Duong Nguyen, Daniel A. Hägg, Alma Forsman, Josefine Ekholm, Puwapong Nimkingratana, Camilla Brantsing, Theodoros Kalogeropoulos, Samantha Zaunz, Sebastian Concaro, Mats Brittberg, Anders Lindahl, Paul Gatenholm, Annika Enejder, Stina Simonsson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3c064b477afd4f1db31a5385f9ae7dfe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3c064b477afd4f1db31a5385f9ae7dfe
record_format dspace
spelling oai:doaj.org-article:3c064b477afd4f1db31a5385f9ae7dfe2021-12-02T11:40:31ZCartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink10.1038/s41598-017-00690-y2045-2322https://doaj.org/article/3c064b477afd4f1db31a5385f9ae7dfe2017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00690-yhttps://doaj.org/toc/2045-2322Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. As a prospective treatment of such lesions, human-derived induced pluripotent stem cells (iPSCs) were shown to be 3D bioprinted into cartilage mimics using a nanofibrillated cellulose (NFC) composite bioink when co-printed with irradiated human chondrocytes. Two bioinks were investigated: NFC with alginate (NFC/A) or hyaluronic acid (NFC/HA). Low proliferation and phenotypic changes away from pluripotency were seen in the case of NFC/HA. However, in the case of the 3D-bioprinted NFC/A (60/40, dry weight % ratio) constructs, pluripotency was initially maintained, and after five weeks, hyaline-like cartilaginous tissue with collagen type II expression and lacking tumorigenic Oct4 expression was observed in 3D -bioprinted NFC/A (60/40, dry weight % relation) constructs. Moreover, a marked increase in cell number within the cartilaginous tissue was detected by 2-photon fluorescence microscopy, indicating the importance of high cell densities in the pursuit of achieving good survival after printing. We conclude that NFC/A bioink is suitable for bioprinting iPSCs to support cartilage production in co-cultures with irradiated chondrocytes.Duong NguyenDaniel A. HäggAlma ForsmanJosefine EkholmPuwapong NimkingratanaCamilla BrantsingTheodoros KalogeropoulosSamantha ZaunzSebastian ConcaroMats BrittbergAnders LindahlPaul GatenholmAnnika EnejderStina SimonssonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Duong Nguyen
Daniel A. Hägg
Alma Forsman
Josefine Ekholm
Puwapong Nimkingratana
Camilla Brantsing
Theodoros Kalogeropoulos
Samantha Zaunz
Sebastian Concaro
Mats Brittberg
Anders Lindahl
Paul Gatenholm
Annika Enejder
Stina Simonsson
Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
description Cartilage lesions can progress into secondary osteoarthritis and cause severe clinical problems in numerous patients. As a prospective treatment of such lesions, human-derived induced pluripotent stem cells (iPSCs) were shown to be 3D bioprinted into cartilage mimics using a nanofibrillated cellulose (NFC) composite bioink when co-printed with irradiated human chondrocytes. Two bioinks were investigated: NFC with alginate (NFC/A) or hyaluronic acid (NFC/HA). Low proliferation and phenotypic changes away from pluripotency were seen in the case of NFC/HA. However, in the case of the 3D-bioprinted NFC/A (60/40, dry weight % ratio) constructs, pluripotency was initially maintained, and after five weeks, hyaline-like cartilaginous tissue with collagen type II expression and lacking tumorigenic Oct4 expression was observed in 3D -bioprinted NFC/A (60/40, dry weight % relation) constructs. Moreover, a marked increase in cell number within the cartilaginous tissue was detected by 2-photon fluorescence microscopy, indicating the importance of high cell densities in the pursuit of achieving good survival after printing. We conclude that NFC/A bioink is suitable for bioprinting iPSCs to support cartilage production in co-cultures with irradiated chondrocytes.
format article
author Duong Nguyen
Daniel A. Hägg
Alma Forsman
Josefine Ekholm
Puwapong Nimkingratana
Camilla Brantsing
Theodoros Kalogeropoulos
Samantha Zaunz
Sebastian Concaro
Mats Brittberg
Anders Lindahl
Paul Gatenholm
Annika Enejder
Stina Simonsson
author_facet Duong Nguyen
Daniel A. Hägg
Alma Forsman
Josefine Ekholm
Puwapong Nimkingratana
Camilla Brantsing
Theodoros Kalogeropoulos
Samantha Zaunz
Sebastian Concaro
Mats Brittberg
Anders Lindahl
Paul Gatenholm
Annika Enejder
Stina Simonsson
author_sort Duong Nguyen
title Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
title_short Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
title_full Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
title_fullStr Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
title_full_unstemmed Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
title_sort cartilage tissue engineering by the 3d bioprinting of ips cells in a nanocellulose/alginate bioink
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3c064b477afd4f1db31a5385f9ae7dfe
work_keys_str_mv AT duongnguyen cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT danielahagg cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT almaforsman cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT josefineekholm cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT puwapongnimkingratana cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT camillabrantsing cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT theodoroskalogeropoulos cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT samanthazaunz cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT sebastianconcaro cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT matsbrittberg cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT anderslindahl cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT paulgatenholm cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT annikaenejder cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
AT stinasimonsson cartilagetissueengineeringbythe3dbioprintingofipscellsinananocellulosealginatebioink
_version_ 1718395575361077248